|
|
Volumn 21, Issue 2, 2002, Pages 260-270
|
|
An optimal experimental design for the development of preservative heart solutions
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACEBUTOLOL;
ADENOSINE;
ALANYLGLUTAMINE;
ASPARTIC ACID;
CALCIUM;
CARDIOPLEGIC AGENT;
CHLORPROMAZINE;
DEFEROXAMINE;
DEXTRAN 70;
DIMETHYL SULFOXIDE;
GLUTATHIONE;
KETAMINE;
MAGNESIUM;
MANNITOL;
NIFEDIPINE;
POLYETHYLENE;
POTASSIUM;
PRESERVATION SOLUTION;
PYRUVIC ACID;
ANIMAL TISSUE;
ARTICLE;
BIOLOGICAL MODEL;
CELL VIABILITY;
CONTROLLED STUDY;
CORONARY ARTERY BLOOD FLOW;
DRUG ANALYSIS;
DRUG EFFECT;
DRUG FORMULATION;
HEART MUSCLE;
HEART PRESERVATION;
NONHUMAN;
OXYGEN CONSUMPTION;
PRIORITY JOURNAL;
SWINE;
ANIMALS;
CELL SURVIVAL;
CORONARY CIRCULATION;
FEMALE;
HEART;
HEART RATE;
MALE;
MYOCARDIUM;
ORGAN PRESERVATION SOLUTIONS;
OXYGEN CONSUMPTION;
RESEARCH DESIGN;
STROKE VOLUME;
SWINE;
TIME FACTORS;
|
|
EID: 0036161528
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/S1053-2498(01)00361-8 Document Type: Article |
|
Times cited : (10)
|
|
References (13)
|
